- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: MGCD0103
Total 31 results
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada
-
Mirati Therapeutics Inc.CompletedNon Hodgkin's Lymphoma | TumorsCanada, United States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaCanada, United States
-
Mirati Therapeutics Inc.TerminatedHodgkin's LymphomaUnited States, Canada
-
Mirati Therapeutics Inc.CompletedLymphomaUnited States, Canada
-
Mirati Therapeutics Inc.TerminatedMyelodysplastic Syndromes | Myelogenous Leukemia, AcuteUnited States, Canada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Zai Lab (Shanghai) Co., Ltd.TerminatedAdvanced Hepatocellular Carcinoma (HCC)China
-
Mirati Therapeutics Inc.CompletedUrothelial CarcinomaUnited States
-
Mirati Therapeutics Inc.CompletedLymphocytic Leukemia, ChronicUnited States, Canada
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
Zai Lab (Shanghai) Co., Ltd.TerminatedUnresectable, Recurrent or Metastatic Melanoma | Untreated Mucosal or Acral Lentiginous MelanomaChina
-
University Health Network, TorontoAstraZeneca; Mirati Therapeutics Inc.WithdrawnSquamous Cell Carcinoma, Head And Neck | Squamous Cell Carcinoma Mouth | Resectable Squamous Cell Carcinoma of Oral CavityCanada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic SyndromeUnited States
-
Lisata Therapeutics, Inc.WithdrawnBrain and Central Nervous System TumorsUnited States
-
Mirati Therapeutics Inc.TerminatedHodgkin Lymphoma | Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)United States
-
MacroGenicsWithdrawnHead and Neck Cancer | Squamous Cell Carcinoma of Head and Neck
-
Memorial Sloan Kettering Cancer CenterMethylGene Inc.CompletedHodgkin LymphomaUnited States
-
Mirati Therapeutics Inc.TerminatedStomach Cancer | Breast Cancer | Gastric Cancer | Lung Cancer | Prostate Cancer | Non-Small-Cell Lung Carcinoma | Prostatic Cancer | Pulmonary CancerUnited States
-
MacroGenicsTerminatedHead and Neck Cancer | Head and Neck Neoplasms | Head and Neck Squamous Cell CarcinomaSpain, United States, Australia, Poland, Ukraine, Bulgaria, Hungary
-
Mirati Therapeutics Inc.CompletedTumorsUnited States, Canada
-
Jonsson Comprehensive Cancer CenterMirati Therapeutics Inc.; Phase One FoundationRecruitingRhabdomyosarcomaUnited States
-
Mirati Therapeutics Inc.TerminatedAdvanced CancerUnited States
-
Mirati Therapeutics Inc.TerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
MacroGenicsZai Lab (Shanghai) Co., Ltd.Active, not recruitingGastric Cancer | Gastroesophageal Junction Cancer | HER2-positive Gastric CancerKorea, Republic of, United States, China, Italy, Taiwan, Germany, Singapore, United Kingdom, Poland
-
Hoffmann-La RocheCompleted
-
MacroGenicsCompletedCervical Cancer | Hematologic Neoplasms | Ovarian Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Small-cell Lung Cancer | TNBC - Triple-Negative Breast Cancer | HER2-positive Advanced Solid TumorsHong Kong, United States, Thailand, Australia, Spain, Bulgaria, Poland, Ukraine
-
NovartisCompletedType 2 Diabetes Mellitus | Impaired Glucose ToleranceUnited States, Canada, Finland, Australia, Germany, India, Italy
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | Gliosarcoma | Newly DiagnosedUnited States